MwanzoONC • TSE
add
Oncolytics Biotech Inc
Bei iliyotangulia
$ 1.25
Bei za siku
$ 1.18 - $ 1.25
Bei za mwaka
$ 1.02 - $ 2.08
Thamani ya kampuni katika soko
92.87M CAD
Wastani wa hisa zilizouzwa
elfu 158.96
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 9.90M | -10.40% |
Mapato halisi | -9.54M | 3.85% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.12 | 10.29% |
EBITDA | -9.86M | 10.56% |
Asilimia ya kodi ya mapato | -0.13% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 19.60M | -50.98% |
Jumla ya mali | 24.26M | -47.36% |
Jumla ya dhima | 15.20M | -10.93% |
Jumla ya hisa | 9.06M | — |
hisa zilizosalia | 77.07M | — |
Uwiano wa bei na thamani | 10.42 | — |
Faida inayotokana na mali | -87.86% | — |
Faida inayotokana mtaji | -167.51% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -9.54M | 3.85% |
Pesa kutokana na shughuli | -4.83M | 19.87% |
Pesa kutokana na uwekezaji | elfu -32.00 | -100.47% |
Pesa kutokana na ufadhili | elfu -173.00 | -100.81% |
Mabadiliko halisi ya pesa taslimu | -5.25M | -123.38% |
Mtiririko huru wa pesa | -1.70M | -171.09% |
Kuhusu
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Ilianzishwa
1998
Makao Makuu
Tovuti
Wafanyakazi
29
